The Clorox Company
CLX
$102.53
-$1.10-1.06%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.95B | 1.67B | 1.67B | 1.43B | 1.99B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.95B | 1.67B | 1.67B | 1.43B | 1.99B |
| Cost of Revenue | 1.14B | 948.00M | 951.00M | 833.00M | 1.06B |
| Gross Profit | 804.00M | 722.00M | 722.00M | 596.00M | 924.00M |
| SG&A Expenses | 516.00M | 407.00M | 452.00M | 444.00M | 469.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 5.00M | 4.00M | 6.00M | 5.00M | 6.00M |
| Total Operating Expenses | 1.70B | 1.39B | 1.44B | 1.31B | 1.57B |
| Operating Income | 251.00M | 284.00M | 235.00M | 119.00M | 417.00M |
| Income Before Tax | 213.00M | 256.00M | 215.00M | 107.00M | 410.00M |
| Income Tax Expenses | 46.00M | 65.00M | 54.00M | 25.00M | 74.00M |
| Earnings from Continuing Operations | 167.00M | 191.00M | 161.00M | 82.00M | 336.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -4.00M | -4.00M | -4.00M | -2.00M | -4.00M |
| Net Income | 163.00M | 187.00M | 157.00M | 80.00M | 332.00M |
| EBIT | 251.00M | 284.00M | 235.00M | 119.00M | 417.00M |
| EBITDA | 333.00M | 342.00M | 290.00M | 175.00M | 482.00M |
| EPS Basic | 1.34 | 1.54 | 1.29 | 0.65 | 2.70 |
| Normalized Basic EPS | 0.98 | 1.30 | 1.06 | 0.48 | 1.99 |
| EPS Diluted | 1.34 | 1.54 | 1.29 | 0.65 | 2.69 |
| Normalized Diluted EPS | 0.98 | 1.30 | 1.05 | 0.48 | 1.98 |
| Average Basic Shares Outstanding | 121.50M | 121.36M | 121.60M | 122.63M | 123.17M |
| Average Diluted Shares Outstanding | 121.81M | 121.79M | 121.92M | 123.02M | 123.74M |
| Dividend Per Share | 1.25 | 1.24 | 1.24 | 1.24 | 1.24 |
| Payout Ratio | 92.02% | 80.21% | 96.18% | 188.75% | 45.18% |